foxo4-dri peptide senolytic 2023 Peptide inhibitors targeting FOXO4-p53 interactions

Bacteria boost mammalian host NAD metabolism by engaging the deamidated biosynthesis pathway

Its storage requirements don't conflict with peptide storage

Key finding: AOD 9604 reduced visceral fat by 38%, improved HOMA-IR by 52%, and corrected glucose intolerance (fasting glucose -28%)

preliminary evidence exists only for osteoarthritis via intra-articular injection Quick Facts Overview & Origin AOD-9604 (Anti-Obesity Drug 9604) is a 16-amino acid peptide comprising the C-terminal fragment of human growth hormone (hGH), specifically residues 177-191 of the native hormone, with an additional tyrosine residue at the N-terminus